FDA Investigator Valerie Jgrecek Trinh

Valerie Jgrecek Trinh has conducted inspections on 335 sites in 1 countries as of 25 Sep 2019. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
335
Last Inspection Date:
25 Sep 2019
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Valerie Jgrecek Trinh:
Abraham M Maekele, Adaliz Santaliz Cruz, Albert A Salvador, Alia Legaux, Alice S Tsao, Althea A Williams, Amanda B Vega, Amber D Brodas, Amy A Johnson, Amy Constantine, Amy H Ruble, Amy Kim, Amy Wyan Mai, Ana Delp Cintron, Ana P Barido, Andrea H Norwood, Andrew F Cohen, Andrew J Mcguffin, Angela E Glenn, Angela Jourdain, Arduino Frankovic, Arthur S Williams, Jr, Ashley A Mutawakkil, Ashley A Segura, Ashley B Jelonek, Barbara Paul, Barbara T Carmichael, Bonita S Chester, Brandy D Brown, Brant M Schroeder, Burnell M Henry, Carl E Lovrich, Carla A Norris, Chad R Burger, Charisse K Green, Cheryl A Clausen, Christopher J Adams, Clara E Santiago, Cody D Rickman, Colleen M Aspinwall, Courtney A Gilbert, Courtney A Hunt, Dave M Deroche, Demitria J Xiradakis, Devaughn Edwards, Diane Hall, Dianiris C Ayala, Dionne D Arline, Dipesh K Shah, Donald J Mee, Donald J Ullstrom, Doretha M Wilson, Dorothy W Lee, Douglas G Ng, Dr. Barbara D Paul, PhD, Dr. Gang Wang, PhD, Dwayne E Dollins, Eric M Padgett, Ethan P Stegman, Evelyn Taha, Fabian Nchaparro Rodriguez, Fatima Bassa, Frank Verni, Gary E Coleman, Jr, REHS, Gayle J Gehrman, Gene D Arcy, George M Ibrahim, German Rivera, Glenn S Quintanilla, Gloria E Parra, Gregson A Joseph, Harry R Bringger, Jr, Haydee B Romero, Helen B Ricalde, Helen R Bester, Holly M Scott, Iram R Hassan, PhD, Irina Gaberman, Ivan E Reyes, Ivy Z Bevill, Jacqueline Mdiaz Albertini, Jana L Caylor, Jane C Chen, Janet B Gray, Jason D Abel, Jennifer A Bazergui, Jennifer L Custodio, Jennifer Macmillan, John E Aghadia, Jolanna A Norton, Jose R Rodriguez, Joseph A Famiglietti, Joseph O Sullivan, Joshua J Silvestri, Joy P Matthias, Joyce A Williams, Juanelma H Palmer, Juanita P Versace, Judy Ellen Ciaraldi, Judy Keihl, Julie D Bringger, Justin A Boyd, Karen M Cruz Arenas, Karen M Rodriguez, Kathleen D Culver, Kellie Leveille, Kenneth L Smalls, Kent C Hermann, Kerun Hardeo, Kevin A Gonzalez, Kimberley A Gordon, Kimberley A Ricketts, Kip J Hanks, L Gnnmassimia Massimilla, PharmD, Laiza V Garcia, Laura E Garcia, Laura M Howard, Laura Schankweiler, LCDR Randall L Morris, Leena Thomas, Leo J Lagrotte, Leon L Crawley, Leroy Terrelonge, Linda K Matheny, Linda M Sacco, Lindsay R Hatch, Lindsay R Mundy, Lisa A Warner, Lisa Mathew, LT Daveta L Bailey, LTJG Matthew R Palo, Lura D Baquero, Lura D Kelly, Madelyn Renteria, Marianna Sala Rhatigan, Marion Michaelis, Marla A Cassidy, Matthew B Thomaston, Megan R Anderson, Melinda B Lewis, Mercy O Quagraine, Meredith P Soehl, Investigator, Michael I Gorman, Michael R Dominick, Michelle D Haamid, Mizanne E Lewis, Mohammad Heidaran, PhD, Nicholas M Smith, Nisha C Patel, Nydia E Colon, Omayra Nrodriguez Ruiz, Ormond, Patty P Kaewussdangkul, Paul L Figarole, Jr, Peter Abel, Peter M Trunk, Randy L Clarida, Raymond A Lyn, Jr, Richard J Bashay, Richard K Vogel, Rita F Monfort, Robert C Steyert, Robert W Mcdowell Jr, Ronnie E Jackson, Rosia E Nesbitt, Salvatore N Randazzo, Samantha J Pinizzotto, D V M, Samuel Eskenazi, Sandra D Thompson, Sarah Forney, Sergio E Delgado, Shavon L Square, Sherbet L Samuels, Shreya Shah, Shusheen A Alexander, Simone E Pitts, Sonia M Monges, Stacey F Rivette, Stanley Noneze, Steven J Libal, Susan M Corrales, Susan M Jackson, Susan M Turcovski, Suzanne M Healy, Taylor G Barker, Thai D Truong, Thomas P Hansen, Traci M Armand, Valerie A Potopsingh, Verdell Nelson, Victoria V Bot, Xiaokuang Lai, PhD, Yong Hu, Yvonne M Santiago

Valerie Jgrecek Trinh's Documents

Publish Date Document Type Title
April, 2017 FDA 483 Response RTI Surgical, Inc. dba RTI Biologics, Inc. - Form 483R, 2017-05-18
October, 2010 FDA 483 RTI Surgical, Inc. dba RTI Biologics, Inc. - Form 483, 2010-10-15
October, 2010 FDA 483 Response RTI Surgical, Inc. dba RTI Biologics, Inc. - Form 483R, 2010-11-02
August, 2000 FDA 483 New York Blood Center, Inc. - Form 483, 2000-08-22
August, 2013 EIR OneBlood, Inc. - EIR, 2013-08-02
March, 2006 FDA 483 Rti Donor Services, N.e. Division - Form 483, 2006-03-23
April, 2016 EIR Alaris Biologic Technologies, Inc. - EIR, 2016-04-29
July, 2002 FDA 483 New York Blood Center Enterprises - Form 483, 2002-07-09
March, 2012 FDA 483 Hemarus, LLC - Form 483, 2012-03-02
February, 2003 FDA 483 New York Blood Center Enterprises - Form 483, 2003-02-28
August, 2003 FDA 483 NYU Hospitals Center - Form 483, 2003-08-26
February, 2003 FDA 483 Response New York Blood Center Enterprises - Form 483R, 2003-04-21
August, 2000 EIR New York Blood Center, Inc. - EIR, 2000-08-22
August, 2000 FDA 483 Response New York Blood Center, Inc. - Form 483R, 2000-11-16
April, 2016 FDA 483 Alaris Biologic Technologies, Inc. - Form 483, 2016-04-29
March, 2002 EIR NYU Hospitals Center - EIR, 2002-03-06
March, 2001 FDA 483 Mount Sinai West - Form 483, 2001-03-21
March, 2001 EIR Mount Sinai West - EIR, 2001-03-21
August, 2010 EIR Schaeffer, David, MD - EIR, 2010-08-02
November, 2018 FDA 483 BPL Plasma, Inc. - Form 483, 2018-11-13
June, 2019 FDA 483 UF Reproductive Medicine at Springhill - Form 483, 2019-06-06
November, 2015 EIR Baptist Medical Center Blood Bank - EIR, 2015-11-18
April, 2017 FDA 483 RTI Surgical, Inc. dba RTI Biologics, Inc. - Form 483, 2017-04-28
July, 2012 FDA 483 RTI Surgical, Inc. dba RTI Biologics, Inc. - Form 483, 2012-07-11
March, 2000 FDA 483 New York Blood Center Enterprises - Form 483, 2000-03-20
August, 2003 FDA 483 Response NYU Hospitals Center - Form 483R, 2003-09-04
October, 2010 EIR RTI Surgical, Inc. dba RTI Biologics, Inc. - EIR, 2010-10-15
July, 2002 FDA 483 Response New York Blood Center Enterprises - Form 483R, 2002-07-26
August, 2003 EIR NYU Hospitals Center - EIR, 2003-08-26
July, 2019 EIR OneBlood, Inc. - EIR, 2019-07-11
March, 2000 EIR New York Blood Center Enterprises - EIR, 2000-03-20

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more